Thank you for your interest in clinical trial participation at the Center for Vaccine Development and Global Health!
Clinical trials look at new ways to prevent, detect, or treat disease. Treatments might be new drugs or new combinations of drugs or new ways to use existing treatments. Each of our clinical trials are different. Clinical trials help determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses.
People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Clinical trials offer hope for many people and an opportunity to help researchers find better treatments for others in the future.
Please complete this contact form to be added to our list of potential participants and to receive our newsletter. We look forward to speaking with you about participation in a trial at the Center for Vaccine Development at the University of Maryland, Baltimore.
CVD Clinical Trials Contact Form
Are you interested in learning more about pediatric trials?
Some of our clinical research trials focus on children. These studies often test investigational vaccines. Each of our clinical trials is different but all are managed by pediatricians and other experts in the field of vaccinology. Dr. James Campbell, one of our pediatricians, was named the 2021 Pediatrician of the Year in Maryland...your kids are in great hands!
Please complete this contact form if you wish your children or children to be added to our list of potential participants and to receive our newsletter. We look forward to speaking with you about participation in a pediatric trial.
Pediatric Studies Contact Form
This research study tests an investigational DNA vaccine for the Hantaan and Puumala viruses which are spread by exposure to rodents.
Shigella vaccine study. Healthy adults 18 – 45 years. 2 outpatient vaccinations and a possible 12-day inpatient stay. Compensation up to $3,150 - $7,350. For more information, please call the Center for Vaccine Development: 410-706-7926.
UMB seeks healthy nonsmokers aged 18-46 years for an inpatient flu study.
Compensation up to $3,410.
Researchers at the University of Maryland School of Medicine are partnering with the public to better understand the spread of COVID-19. Study participants will complete short online questionnaires over several months about possible exposures to COVID-19, symptoms, and health care visits.